TET1 and neoplasm: In pancreatic cancer cells, TET1 inhibited tumor growth by suppressing the WNT/β-catenin pathway by elevating the expression of SFRP2, an upstream inhibitor of the WNT/β-catenin pathway, via enhanced 5mC oxidation at its promoter [104].